1.
Ann Rheum Dis
; 81(7): e131, 2022 07.
Article
in English
| MEDLINE | ID: covidwho-2309132
Subject(s)
Antirheumatic Agents , Biological Products , COVID-19 , Janus Kinase Inhibitors , Rheumatic Diseases , Antirheumatic Agents/therapeutic use , Biological Products/therapeutic use , Humans , Incidence , Janus Kinase Inhibitors/therapeutic use , Rheumatic Diseases/drug therapy , Rheumatic Diseases/epidemiology
2.
Ann Rheum Dis
; 81(7): e131, 2022 07.
Article
in English
| MEDLINE | ID: covidwho-614712